HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (35) Citing Articles via Google Scholar Google Scholar Articles by Ferré, N. Articles by Joven, J. Search for Related Content PubMed PubMed Citation Articles by Ferré, N. Articles by Joven, J. Related Collections Proteomics and Protein Markers

Serum Paraoxonase Activity: A New Additional Test for the Improved Evaluation of Chronic Liver Damage

¹ Centre de Recerca Biomèdica and
² Servei de Medicina Interna, Institut de Recerca en Ciències de la Salut (IRCIS), Hospital Universitari de Sant Joan, C/. Sant Joan s/n, 43201-Reus, Catalunya, Spain.

^aAuthor for correspondence. Fax 34-977-312569; e-mail jcamps{at}grupsgs.com.

Background: Paraoxonase 1 (PON1) is an ester hydrolase present in serum and in the liver. The aims of the present study were to investigate the following: (a) the relationship between serum PON1 activity alterations and the degree of liver damage in patients with chronic liver disease; (b) the influence of genetic variability on serum PON1 activity; and (c) the efficacy of serum PON1 activity measurement, alone and in combination with standard liver function tests, in the assessment of liver damage.

Methods: We studied 68 patients with liver cirrhosis, 107 patients with chronic hepatitis, and 368 apparently healthy volunteers. Baseline and salt-stimulated PON1 activities were measured by the hydrolysis of paraoxon. PON1 genotyping at positions 55 and 192 was analyzed by PCR and restriction isotyping.

Results: Baseline and stimulated PON1 activities were decreased (P <0.001) in chronic hepatitis and in liver cirrhosis. PON1 activity was significantly correlated with serum total proteins, albumin, and bilirubin in patients but not in controls. There were no significant differences with respect to allele and genotype frequencies between patients and controls. The combination of baseline serum PON1 with five standard biochemical tests had a higher classification accuracy (94% of patients; 96% of controls) than the five standard tests alone (75% of patients; 96% of controls). ROC plots demonstrated a high diagnostic accuracy for baseline serum PON1 [area under the curve, 0.89 (95% confidence interval, 0.86–0.93) in chronic hepatitis and 0.96 (95% confidence interval, 0.94–0.99) in cirrhosis]. Baseline PON1 provided the highest ROC area for cirrhosis vs controls.

Conclusions: The significant decrease of PON1 activity in chronic liver diseases is related to the degree of hepatic dysfunction and not to allelic or genotypic differences. Addition of serum PON1 activity measurement to the current battery of tests may improve the evaluation of chronic liver diseases.

The following articles in journals at HighWire Press have cited this article:

				A. S. Farid, K. Nakahara, N. Murakami, T. Hayashi, and Y. Horii Decreased Serum Paraoxonase-1 Activity during Intestinal Nematode (Nippostrongylus brasiliensis) Infection in Rats Am J Trop Med Hyg, May 1, 2008; 78(5): 770 - 776. [Abstract] [Full Text] [PDF]

				M. Bionaz, E. Trevisi, L. Calamari, F. Librandi, A. Ferrari, and G. Bertoni Plasma Paraoxonase, Health, Inflammatory Conditions, and Liver Function in Transition Dairy Cows J Dairy Sci, April 1, 2007; 90(4): 1740 - 1750. [Abstract] [Full Text] [PDF]

				E. Thomas-Moya, M. Gianotti, A. M. Proenza, and I. Llado The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats J. Lipid Res., September 1, 2006; 47(9): 2042 - 2048. [Abstract] [Full Text] [PDF]

				D. E. Amacher, R. Adler, A. Herath, and R. R. Townsend Use of Proteomic Methods to Identify Serum Biomarkers Associated with Rat Liver Toxicity or Hypertrophy Clin. Chem., October 1, 2005; 51(10): 1796 - 1803. [Abstract] [Full Text] [PDF]

				N. Ferre, J. Camps, J. Marsillach, B. Mackness, M. Mackness, B. Coll, M. Tous, and J. Joven Comparison of Paraoxonase 1 Measurements in Serum and in Lithium-Heparin-Anticoagulated Plasma Samples Clin. Chem., May 1, 2005; 51(5): 922 - 923. [Full Text] [PDF]

				B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine Clin. Chem., March 1, 2004; 50(3): 530 - 536. [Abstract] [Full Text] [PDF]

				N. Ferre, J. Camps, J. Fernandez-Ballart, V. Arija, M. M. Murphy, S. Ceruelo, E. Biarnes, E. Vilella, M. Tous, and J. Joven Regulation of Serum Paraoxonase Activity by Genetic, Nutritional, and Lifestyle Factors in the General Population Clin. Chem., September 1, 2003; 49(9): 1491 - 1497. [Abstract] [Full Text] [PDF]